$GURE oil prices up up up pump da oil. Gure to launch. Top play. Dont be late. Be gurrrrrrrrrreeeeeeee ate
$BTOG yea lets gooo
$SOBR wonderful
$BTTX can go here
$INBS top ww
@ChaseDeluca FEMY is pure potential right now. New tech direction. Permanent birth control with no operation? That combo alone is worth paying attention to. And when nobody’s looking… that’s when real moves happen.
$QCLS $ZVSA $GDC $BTTX $IQST
$YYAI $INTS $ATCH $BTTX $WOK 🚨
/ EPWK/ADTX/ BURU//GPUS/ NUAI🚨
Attention everyone 👇👇👇🚨🐺
This is the only account I have, the one with 13.7K followers.
I don’t have any other account,
All the other accounts are fake scammers copying me.
All my posts here on StockTwits only.
I’m trying to help everyone with my experience🫶🫶🫶🐺
Stay tuned everyone 👀👀🐺
TOMORROW Let’s go💰💵💰
All my followers are making bank 🏦
You all gonna be rich 🤑
$HCTI — Recurring growth + scale in motion.
QuantumNexis on Ezovion has processed 20M and projects 37M in the coming months, with a payment gateway to monetize volume via recurring fees. That’s adoption + a clear take-rate path.
At $2.86, the market is still pricing HCTI like there’s no platform leverage. Against small-cap health/telehealth comps, even a conservative EV/Sales band suggests well below fair value while execution improves.
What I’m watching next: gateway go-live, regional wins (India/KSA/MY), and continued usage growth.
Spec peers to track: $AMWL $ONMD $BTTX
#DigitalHealth #AIinHealthcare #RecurringRevenue
MITQ is in prime breakout territory:
Golden cross forming, float nearly nonexistent, and no one’s paying attention yet.
This setup screams stealth runner.
If a headline drops, this won’t move it’ll gap.
$INM $OBSV $LGVN $BTTX $AKAN
$HCTI 💡 While the market keeps selling off, $HCTI is getting pulled into the vortex of exiting liquidity like everything else. But here’s the difference → healthcare IT isn’t cyclical, it’s mission-critical. Compliance, cybersecurity & efficiency solutions don’t vanish in a downturn—they get prioritized.
📉 Politicians can cook the numbers all they want, but let’s be real: we’re already in a recession. And in recessions, hospitals + insurers cut costs by modernizing tech… exactly where HCTI is positioned with CloudEZ, DataEZ & HealthEM.AI.
⚡️ When the dust settles and liquidity rotates back in, undervalued gems like this will bounce harder. $HCTI rockets on small volume, so imagine what happens when real buyers return.
Steady hands here win. #AI #Healthcare $TDOC $BTTX
$BTTX Innovative digital health play with FDA-approved diabetes solution. AspyreRx looks promising. Watching closely for commercial traction and potential partnerships. CBT approach could be game-changer for cardiometabolic management. compelling writeup: https://beyondspx.com/article/better-therapeutics-bttx-pioneering-digital-therapeutics-for-cardiometabular-conditions
